Only men with prostate tumors of the luminal B subtype benefited from adding apalutamide to salvage radiation in the phase 2 ...
The study found that patients with luminal B subtype prostate cancer benefited from the addition of hormone therapy to ...
A genetic test could guide the use of hormone therapy for men with recurrent prostate cancer after surgery, according to data ...
It’s the second most common type of cancer among men and affects 1 in every 8 men in the United States. September is Prostate Cancer Awareness Month, and the American Cancer Society says this type of ...
PANAMA CITY, Fla. (WJHG/WECP) - Hope Regional Medical Center in Panama City is now using a powerful new diagnostic tool in the fight against Prostate Cancer. Doctors at the center have always used CT ...
A preclinical evaluation of a new ’dual-mode’ tracer agent shows promise in not only helping surgeons image and plan prostate ...
GRENOBLE, France, Nov. 20, 2024 (GLOBE NEWSWIRE) -- Koelis, SAS (“Koelis” or the “Company”, www.koelis.com), a global leader and innovator in prostate care, announced today passing an important ...
Prostate cancer stages explain how far cancer has spread. Stage 1 and 2 stay in the prostate and are highly treatable. Stage 3 spreads to nearby tissues, while stage 4 reaches distant organs. PSA ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback